X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs DIVIS LABORATORIES - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA DIVIS LABORATORIES SANOFI INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 29.7 18.1 163.9% View Chart
P/BV x 5.2 3.9 133.7% View Chart
Dividend Yield % 1.7 1.6 109.0%  

Financials

 SANOFI INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
DIVIS LABORATORIES
Mar-16
SANOFI INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4,5602,484 183.6%   
Low Rs4,400918 479.3%   
Sales per share (Unadj.) Rs1,028.5142.3 723.0%  
Earnings per share (Unadj.) Rs129.041.9 307.9%  
Cash flow per share (Unadj.) Rs186.046.3 401.4%  
Dividends per share (Unadj.) Rs68.0010.00 680.0%  
Dividend yield (eoy) %1.50.6 258.2%  
Book value per share (Unadj.) Rs753.6161.5 466.6%  
Shares outstanding (eoy) m23.03265.47 8.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.412.0 36.4%   
Avg P/E ratio x34.740.6 85.5%  
P/CF ratio (eoy) x24.136.7 65.6%  
Price / Book Value ratio x5.910.5 56.5%  
Dividend payout %52.723.9 220.8%   
Avg Mkt Cap Rs m103,174451,525 22.9%   
No. of employees `0003.63.7 97.7%   
Total wages/salary Rs m3,5923,649 98.4%   
Avg. sales/employee Rs Th6,537.710,184.4 64.2%   
Avg. wages/employee Rs Th991.4984.1 100.7%   
Avg. net profit/employee Rs Th819.82,998.5 27.3%   
INCOME DATA
Net Sales Rs m23,68637,764 62.7%  
Other income Rs m708848 83.5%   
Total revenues Rs m24,39438,612 63.2%   
Gross profit Rs m5,28114,138 37.4%  
Depreciation Rs m1,3131,182 111.1%   
Interest Rs m1523 64.7%   
Profit before tax Rs m4,66113,781 33.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6912,662 63.5%   
Profit after tax Rs m2,97011,119 26.7%  
Gross profit margin %22.337.4 59.6%  
Effective tax rate %36.319.3 187.8%   
Net profit margin %12.529.4 42.6%  
BALANCE SHEET DATA
Current assets Rs m15,67330,947 50.6%   
Current liabilities Rs m6,6785,195 128.5%   
Net working cap to sales %38.068.2 55.7%  
Current ratio x2.36.0 39.4%  
Inventory Days Days76117 65.1%  
Debtors Days Days2285 26.2%  
Net fixed assets Rs m8,09817,027 47.6%   
Share capital Rs m230531 43.4%   
"Free" reserves Rs m17,08842,341 40.4%   
Net worth Rs m17,35642,877 40.5%   
Long term debt Rs m05 0.0%   
Total assets Rs m25,40049,684 51.1%  
Interest coverage x311.7595.0 52.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.8 122.7%   
Return on assets %11.822.4 52.4%  
Return on equity %17.125.9 66.0%  
Return on capital %26.932.2 83.7%  
Exports to sales %24.585.3 28.7%   
Imports to sales %28.022.9 122.1%   
Exports (fob) Rs m5,80132,198 18.0%   
Imports (cif) Rs m6,6278,654 76.6%   
Fx inflow Rs m7,14532,270 22.1%   
Fx outflow Rs m6,8468,775 78.0%   
Net fx Rs m29923,496 1.3%   
CASH FLOW
From Operations Rs m3,22610,379 31.1%  
From Investments Rs m-1,555-4,135 37.6%  
From Financial Activity Rs m-1,818-6,241 29.1%  
Net Cashflow Rs m-1473 -4,454.5%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 11.8 122.0%  
FIIs % 14.6 19.0 76.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.2 61.0%  
Shareholders   15,184 31,796 47.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   WOCKHARDT LTD.  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Realty Sector Up 2.7%(11:30 am)

After opening the day higher, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 23, 2017 12:13 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - MERCK LTD COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS